Rewind Therapeutics

Antwerp, Belgium

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

Jan 2023

Series A

Biotechnology Therapeutics

Top Investors

Boehringer Ingelheim Venture Fund Sunstone Life Science Ventures M Ventures Centre for Drug Design & Discovery (CD3)Gemma Frisius Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rewind Therapeutics

Who are Rewind Therapeutics's investors?

Rewind Therapeutics's investors include Boehringer Ingelheim Venture Fund, Sunstone Life Science Ventures, M Ventures, Centre for Drug Design & Discovery (CD3), Gemma Frisius Fund.

Where is Rewind Therapeutics headquartered?

Rewind Therapeutics is headquartered in Antwerp, Belgium.

What does Rewind Therapeutics do?

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

What stage is Rewind Therapeutics at?

Rewind Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 25, 2023.

MLA

"Rewind Therapeutics — Funding & Investors." VCBacked, January 25, 2023, https://www.vcbacked.co/company/rewind-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Rewind Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rewind-therapeutics

Wikipedia (cite web)

{{cite web |title=Rewind Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rewind-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 25, 2023.